Search

Displaying results 9061 - 9070 of 10000 in total
  1. Drug

    Licofelone

    go.drugbank.com/drugs/DB04725
    Experimental

    It is currently under evaluation as a treatment for osteoarthritis (OA), the most common form of arthritis. … Although phase III trials have been successfully completed in OA patients no dates for regulatory submission have yet been given.

  2. Drug

    S-Hydroxycysteine

    go.drugbank.com/drugs/DB01915
    Experimental

    These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. … S-hydroxycysteine is a solid. This compound belongs to the alpha amino acids and derivatives.

  3. Drug

    Talabostat

    go.drugbank.com/drugs/DB06182
    Investigational

  4. Drug

    Inosine 5'-sulfate

    go.drugbank.com/drugs/DB05973
    Experimental

  5. Drug

    Rubitecan

    go.drugbank.com/drugs/DB06159
    Investigational

    Categories: Topoisomerase I Inhibitors
  6. Drug

    Plevitrexed

    go.drugbank.com/drugs/DB06163
    Investigational

  7. Drug

    Mebutamate

    go.drugbank.com/drugs/DB06797
    Approved

    Mebutamate is a sedative and anxiolytic drug with anti-hypertensive (blood pressure lowering) effects comparable to those of other barbiturates but is only around 1/3rd the potency of secobarbital as a

  8. Drug

    Alpibectir

    go.drugbank.com/drugs/DB21561
    Investigational

    Alpibectir is a small molecule drug. … Alpibectir is under investigation in clinical trial NCT06748937 (A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide).

  9. Drug

    Ceperognastat

    go.drugbank.com/drugs/DB21591
    Investigational

    Ceperognastat is a small molecule drug. … Ceperognastat is under investigation in clinical trial NCT05063539 (A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease).

  10. Drug

    Ranosidenib

    go.drugbank.com/drugs/DB21727
    Investigational

    Ranosidenib is a small molecule drug. Ranosidenib is under investigation in clinical trial NCT06387069 (A Study to Evaluate HMPL-306 in Patients With IDH1- and IDH2-mutated Acute Myeloid Leukemia).